USFDA concludes inspection of Indoco’s Rabale facility
May 20, 2024
Source: drugdu
103
Indoco Remedies announced that the United States Food and Drug Administration (USFDA) successfully completed inspection of its API Kilo Lab manufacturing facility at Rabale, Navi Mumbai and Indoco Analytical Solutions (IAS) division. The inspection concluded with zero Form 483 observations.
“We remain committed to ensuring the safety and efficacy of our products while maintaining the trust of our customers and stakeholders”, said Aditi Panandikar, MD, Indoco Remedies.
https://www.expresspharma.in/usfda-concludes-inspection-of-indocos-rabale-facility/
By editor
Copyright©2024 Ddu. All rights reserved.
Read more on
- Global orthopedic giant CEO may be dismissed November 15, 2024
- Johnson&Johnson Medical Technology, organizational restructuring November 15, 2024
- Uncovering the truth of AbbVie’s $8.7 billion lesson November 15, 2024
- Hospitals have a 152-day payment period, and many places have taken action to manage it November 15, 2024
- 374-year-old Chinese time-honored brand will change hands November 15, 2024
your submission has already been received.
OK
Subscribe
Please enter a valid Email address！
Submit
The most relevant industry news & insight will be sent to you every two weeks.
